Filed Pursuant to Rule 424(b)(3)
Registration No. 333-224990
AMENDMENT NO. 1 DATED NOVEMBER 20, 2019
to Prospectus Supplement dated September 13, 2019
(to Prospectus dated May 23, 2018)
BLUEROCK RESIDENTIAL GROWTH REIT, INC.
Up to $100,000,000 of
Class A Common Stock
This Amendment No. 1 to Prospectus Supplement, or this amendment, amends our prospectus supplement dated September 13, 2019, or the prospectus supplement. This amendment should be read in conjunction with the prospectus supplement and the prospectus dated May 23, 2018, each of which are to be delivered with this amendment. This amendment amends only those sections of the prospectus supplement listed in this amendment; all other sections of the prospectus supplement remain as is.
We previously entered into the At Market Issuance Sales Agreement, or the Original Sales Agreement, with B. Riley FBR, Inc., as sales agent or principal, relating to the issuance and sale from time to time of our Class A common stock, par value $0.01 per share, having an aggregate offering price of up to $100,000,000. We have amended and restated the Original Sales Agreement, or the Sales Agreement, to add Robert W. Baird & Co. Incorporated, Compass Point Research & Trading, LLC and JMP Securities LLC with B. Riley FBR, Inc., or the Sales Agents, as sales agents or principals thereunder.
Sales of shares of our Class A common stock will be made by the Sales Agents in sales deemed to be “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. The Sales Agents are not required to sell any specific number or dollar amount of securities, but will act as sales agents using commercially reasonable efforts consistent with normal trading and sales practices, on mutually agreed terms between the Sales Agents and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
The Sales Agents will be entitled to a commission of up to 2.0% of the gross sales proceeds from the sale of shares of Class A common stock under the Sales Agreement. In connection with the sale of the Class A common stock on our behalf, each of the Sales Agents will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the Sales Agents will be deemed to be underwriting commissions or discounts. We have also agreed to indemnify the Sales Agents with respect to certain liabilities, including liabilities under the Securities Act. The net proceeds from any sales under the prospectus supplement will be used as described under “Use of Proceeds” in the prospectus supplement.
Investing in our Class A common stock involves a high degree of risk. You should carefully read and consider “Risk Factors” beginning on page S-5 of the prospectus supplement, page 7 of the accompanying prospectus, in our most recent
Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on February 27, 2019, and under similar headings in the other documents that are incorporated by reference into the prospectus supplement, as amended, or the accompanying prospectus for a discussion of the risks that should be considered before you invest in our Class A common stock.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this amendement, the prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| B. Riley FBR | | | Baird | | | Compass Point | | | JMP Securities | |
Amendment No. 1 to Prospectus Supplement Dated November 20, 2019